RGT Wealth Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | $289K | Buy |
2,150
+15
| +0.7% | +$2.02K | 0.05% | 60 |
|
2022
Q2 | $327K | Sell |
2,135
-126
| -6% | -$19.3K | 0.05% | 65 |
|
2022
Q1 | $367K | Buy |
2,261
+126
| +6% | +$20.5K | 0.06% | 63 |
|
2021
Q4 | $289K | Hold |
2,135
| – | – | 0.04% | 74 |
|
2021
Q3 | $230K | Sell |
2,135
-909
| -30% | -$97.9K | 0.05% | 45 |
|
2021
Q2 | $343K | Sell |
3,044
-103
| -3% | -$11.6K | 0.06% | 34 |
|
2021
Q1 | $341K | Sell |
3,147
-918
| -23% | -$99.5K | 0.07% | 33 |
|
2020
Q4 | $436K | Buy |
+4,065
| New | +$436K | 0.09% | 36 |
|
2020
Q3 | – | Sell |
-2,358
| Closed | -$232K | – | 41 |
|
2020
Q2 | $232K | Buy |
+2,358
| New | +$232K | 0.07% | 33 |
|
2016
Q4 | – | Sell |
-3,794
| Closed | -$239K | – | 123 |
|
2016
Q3 | $239K | Buy |
+3,794
| New | +$239K | 0.15% | 90 |
|